Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanette Dupont Rønlev

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|March 27, 2024
Christina Annette Bjerre, Jeanette Dupont Rønlev, Ann Søegaard Knop
Danish Medical Journal|October 10, 2025
Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancerLaurits Sebastian Dahl, Ann Søegaard Knoop, Maj-Britt Jensen, et al.
BJC Reports|November 8, 2024
Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancerMathilde Louise Gehrchen, Tobias Berg, Rasmus Garly, et al.
Breast (Edinburgh, Scotland)|February 20, 2025
Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional studyNina Lykkegaard Gehr, Signe Timm, Kristine Bennedsgaard, et al.
Breast Cancer Research and Treatment|July 11, 2025
A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trialAnne Sofie Brems-Eskildsen, Julia Kenholm, Annette Torbøl Brixen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|March 27, 2024
Christina Annette Bjerre, Jeanette Dupont Rønlev, Ann Søegaard Knop
Danish Medical Journal|October 10, 2025
Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancerLaurits Sebastian Dahl, Ann Søegaard Knoop, Maj-Britt Jensen, et al.
BJC Reports|November 8, 2024
Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancerMathilde Louise Gehrchen, Tobias Berg, Rasmus Garly, et al.
Breast (Edinburgh, Scotland)|February 20, 2025
Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional studyNina Lykkegaard Gehr, Signe Timm, Kristine Bennedsgaard, et al.
Breast Cancer Research and Treatment|July 11, 2025
A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trialAnne Sofie Brems-Eskildsen, Julia Kenholm, Annette Torbøl Brixen, et al.
Pageof 1